Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...

A clear picture of Thermo Fisher Scientific's perception ... segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and ...

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher ... Scientific Iliad scanning from transmission electron microscope, which integrates a number of advanced analytical ...

It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $665.00.

Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2024 adjusted earnings per share (EPS) of $6.10 beat the Zacks Consensus Estimate by 2.9%. The figure increased 7.6% year over year. The adjusted ...